Wednesday, April 18, 2007

Calls of Note Part 3

- Baird notes that although Komag (NASDAQ:KOMG) already preannounced (positive revenue) Q1 on March 21, Seagate's downward revision to Q2 estimates implies Komag could see some softness in Q2 as well. Firm notes that unit demand is the key metric for KOMG and that most of Seagate's margin/estimate reductions are driven by more competition/aggressive pricing (which would not impact KOMG and could actually help drive unit demand).

Given Seagate results, they are lowering 2007 EPS estimate to $3.90 from $4.00, driven by a weaker 1H profit picture. 2008 estimate is 4.50. Firm is lowering their price target to $39 from $44, based on 10x new 2007 EPS estimate of 3.90.

Given already negative sentiment and meaningful estimate reductions over the past few quarters, they believe a sentiment and fundamental trough is near and encourage value investors to accumulate shares on the near-term weakness. With a strong industry position, multiple growth drivers and prospects for meaningfully stronger results in 2H (from increased unit demand) amid reasonable valuation (<8x 2007 EPS), the firm maintains their Outperform rating.

Notablecalls: KOMG's chart sure looks weak here. Most of co's top customers have the ability to manufacture disk platters internally. This is the main reason why KOMG's stock trades at such a low valuation.

Calls of Note Part 2

- Piper Jaffray comments on Google (NASDAQ:GOOG) in light on Yahoo's Q1 results saying that due to the opinions of SEMs and the positive results coming from Comscore, they believed that Yahoo's Panama search monetization engine would drive upside in Q1. They were wrong, and now are slightly more cautious coming into Google's quarter. Assuming Comscore is at least directionally and relatively accurate (a potentially dangerous assumption), the Yahoo results may indicate that Comscore was simply overestimating paid click growth q/q, a scenario which is troublesome given Google's relatively low q/q growth of 5% according to Comscore. Yahoo's performance, however, has not correlated with Google's in the past. Combined with Google's announced reduction in ad coverage, these results make them at least incrementally more cautious coming in to Q1 results.

Int'l monetization and usage is growing much faster than the more mature U.S. market, and the firm believes Google has continued to gain share internationally, particularly in Europe. Strong international results may be enough to counter any weakness in the U.S. due to reduced ad coverage to allow Google to show the 12% sequential revenue growth consensus is expecting.

Although they believe Panama did well with large advertisers, some of whom may have slightly reduced Google spend in February due to a sudden flood of clicks from Yahoo, they believe Yahoo's new search monetization system hurt many smaller advertisers. It seems reasonable to assume these smaller advertisers may have shifted budgets toward Google.

Notablecalls: Not actionable but good to know category.

Calls of Note Part 1

- RBC Capital notes that despite several announcements yesterday, including a new silicon
contract and Evergreen-only plant expansion (outside of the EverQ venture), they must remain cautious on the long-term outlook for Evergreen Solar (NASDAQ:ESLR).

Firm believes the fundamental advantage of ESLR's technology, the ability to use less silicon to make a solar cell (albeit a less efficient one than industry avg) is of severely depreciating value given the vast amount of new silicon supply (a commodity) coming to market in 2008+. RBC believes silicon prices will rapidly decline in 2009+ and therefore be a much smaller lever on costs going forward.

Earnings Leverage: In order to secure the 6-year silicon deal with new silicon entrant DC Chemical, ESLR granted DCC $130M worth of stock, diluting the company 21%. Share count will approach 100M shares by the end of this year. Management is guiding investors to look to 2009 or 2010 for profits.

Bottom Line: They believe all the news investors were anticipating is now in the stock, with few catalysts that will drive upside. Firm believes the YTD appreciation in shares is primarily a result of short covering, spill-over from overall solar enthusiasm, and speculation about the deals announced yesterday, but they believe the financial and technical outlook for the company bode poorly long-term. Maintains Underperform.

Notablecalls: Good points by RBC's Stuart Bush.

Color on quarter: Yahoo (NASDAQ:YHOO)

Yahoo (NASDAQ:YHOO) is getting little love from the analyst community after reporting its Q1 results last night:

- Deutsche Bank notes they remain on the sidelines on shares of Yahoo! after in-line 1Q results. With the stock down 9% in after hours trading, they think the stock at this point could still face more downside pressure. At $29.50, the stock is trading at 36x 2007 and 29x 2008 earnings estimates, in-line with the Internet Media group at 36x '07 and 27x '08 earnings, but with slower growth (15-20% vs. group at 20%-25%).

Despite positive commentary by management at an industry conference for Panama, search results did not deliver 1Q upside. The high expectations were muted by only a modest contribution from Panama, with flat PPC rates and slower decline on RPS. Meanwhile, the display ad segment grew only 20%Y/Y vs. DB's 25%Y/Y estimate and below its historical rates of 30-35%. Firm thinks there is an oversupply of inventory on the non-premium side and the proliferation of the social networking sites will continue to pressure pricing.

For 2Q, they now expect $1,260mn in revenues, $486mn in EBITDA and $0.12 in GAAP EPS and 2007 estimates are now $5,226mn in revenues (+15% Y/Y), $2,115mn in EBITDA and $0.54 in GAAP EPS, versus prior estimates of $5,249mn, $2,125mn and $0.55 respectively.

- Piper Jaffray notes Yahoo generated net revenue of $1,183M, below their estimate of $1,201M and Street consensus of $1,208M, and even further below recent positive sentiment and firm's conviction that the company would see upside due to better than expected Panama results. PJ notes their enthusiasm about Panama likely should have been tempered by a historical perspective that Yahoo nearly always dead-centers their guidance, as they did this quarter producing net revenue within $8M of the mid-point of their guidance and EBITDA within $35K.

Is Panama Working? The answer seems to be yes, but not nearly as well or as quickly as the firm had thought. Monetization growth was likely slowed by weakness from small customers overpowering the increased spend seen by large branded search advertisers.

They believe Yahoo will be in a "show me" box on Wall Street for some time to come. At $30 per share, Yahoo trades at approximately 22x EV to 2008 PF net income (the best metric due to Yahoo's structurally higher tax rate and large cash and investment positions), while
Google, a company with far faster growth, more market power, and better earnings history trades at 23x. Maintains Mkt Perform and $30 tgt.

- Stifel says YHOO has three core components to its business " search, branded or display
advertisements, and fees. In the quarter, the search business did not show any early signs of material marketplace improvements as was increasingly suggested (and priced in) throughout the quarter. Overall, YHOO saw a revenue per search decline in the quarter, which was weakest at the beginning of the quarter and strengthened to turn positive by the end. To be fair, the company stated on its last call to not expect improvements until 2Q. In the branded business, the company noted that its top-200 advertisers grew by 20% in the quarter compared to 25%-30% in 4Q06 and 33% in 3Q06. In the fees business, the company saw paying customer growth of 24% but reported fees revenue growth of only 9% (10%- 11% after one-time adjustment). All in, YHOO has two components of its business showing noticeable decelerating trends and one in the midst of a restructuring in which management is betting on a double-digit 2H improvement. At 27x fully- taxed 2008 FCF estimates, they believe investors can afford to be patient and possibly attain shares in the low-to-mid $20s within this calendar year. Maintains Hold.

- ThinkEquity is reiterating their Buy rating and 12-month price target of $36. While Yahoo! (YHOO) reported an in-line 1Q07, they believe growth should begin re- accelerating in 2Q07 and the company remains well positioned to outperform 2H07/FY08 as monetization improvements in both search and display build momentum. Firm also believes YHOO's leading positions in video, mobile, and social media should drive greater user growth, further increasing the company's long-term advertising opportunity. They expect YHOO's planned marketing push in 2Q07, the upcoming TV upfront, and the announcement of key hires, e.g. CFO and Head of Audience, to act as potential near-term catalysts.

YHOO indicated that revenue-per-search (RPS) Y/Y declines stabilized in 1Q07 and that the
company is seeing strong increases in click-through-rates (CTRs) and improved cost-per-clicks (CPCs) heading in 2Q07. YHOO also announced that Panama's Japan rollout in 2Q07 remains on track, and the company should roll out Panama to Korea and Europe in the near future. Firm's checks indicate strong adoption trends/approval ratings from advertisers, and they believe the long-term opportunity for improved search monetization remains +40-50%, as YHOO is forecasting double-digit growth in overall revenue per page view in 2H07. They also believe YHOO will begin to add display and video advertising products to the Panama advertising system in the coming months which could further accelerate advertising yield.

Notablecalls: I have mixed emotions regarding Yahoo. On the bearish side, display ad segment growth is deaccelerating as there seems to be growing competition that is driving pricing down. Also, search is not doing too great as revenue per search is going down. Fee revenue grew only 9% y/y while customers grew 24%. On top of that, the valuation is still quite high. On the positive side, Panama's just starting to gain traction. Remember, it was only launched in Feb, giving it half a quarter to prove itself. With the upcoming launches in Japan and Europe Panama's impact may become more visible over the next couple of quarters. Plus, if ThinkEquity's right about the addition of display and video advertising products to the Panama advertising system, there could be significant upside.

Overall, while there are many negatives to the story, I think last night's reaction was a bit too harsh. Sitting back at my old desk, I would put out some early bids around $29 to catch the panic sellers. Would risk around $0.50.

Paperstand (LAUR, BRP, AMX, KEY)

The WSJ’s ”Heard on the Street” column out saying that even as the coffers of private-equity firms have bulged in recent years, Wall St. has always assumed that buyout specialists would be wary of certain industries, such as financial services. These co’s usually have heavy capital requirements and already are loaded with borrowed money. Adding more debt as part of a LBO, could cripple their credit ratings and make it too expensive to raise money to run their businesses. These kinds of co’s also are often heavily regulated, and buyout specialists usually are wary of any tussles with govt bodies. But the slated purchase of SLM (SLM) has investors searching for other financial stocks that might be tgts. In fact, investment bankers say other buyout shops are discussing acquisitions of undervalued financial co’s, even including some banks. Among those that could be takeover bait are Countrywide Financial (CFC), CIT Group (CIT) and iStar (SFI). The fact that Blackstone also vied for Sallie Mae suggests that other private-equity firms could be eager for these kinds of deals. Another tgt is KeyCorp (KEY). One investment banker said KeyCorp might see some improvement with a buyout partner. Private-equity firms are getting so big and diversified that regulators might be more comfortable with those firms owning a bank, he added. "It's more challenging to do a deal for a mortgage player or a credit-card or auto lender than with Sallie Mae," says Richard Hofmann, of CreditSights. "But they're increasingly likely to be LBO tgts now that Sallie Mae has received such a large premium."

Barron’s Onlin saying that the best way to catch the growth of exploding broadband may be in emerging mkt stocks such as Brasil Telecom (BRP), one of the three largest fixed-line phone operators in Brazil, and America Movil (AMX), which provides cellphone service in Colombia, Ecuador and other parts of Latin America and which has double-digit operating profit growth. Both stocks are up smartly this year, with America Movil rising 13% and Brasil Telecom up 23%. But both could also see upside of 20% from their current value, to share prices in the neighborhood of $60 each. Neither co is exposed to the kind of rapid erosion of traditional phone lines that threatens AT&T, and, more important, both are seeing rapid expansion of wireless calling and broadband Internet access, the kinds of high-growth mkts telecom investors are betting on. Finding outperformance in foreign mkts means getting in early before explosive growth in communications is generally apparent. "There is a tipping point that happens in mkts, beyond which growth just takes off beyond what anyone could have expected," says Bill Hughes, of In-Stat. "If you have investments in a lot of different countries, when that tipping point comes, it's going to be a great investment."

“Inside Scoop” section highlights Laureate (LAUR), which in Jan agreed to be acquired. Since then, however, 3 of the co's top shareholders, Select Equity, T. Rowe Price and BlackRock, have voiced their opposition to the buyout. Combined, the 3 firms own 21% of Laureate's outstanding. Now, Select has increased its stake in the co, disclosing that it has raised its stake to 9.8% up from the 8.7% stake it had in Feb. Select spent $33.1m for the additional shares. Joshua Hong, of OwnershipAnalyzer.com, points out that investors still do not know what Laureate's second largest shareholder, William Blair, which owns a 9.6% stake, thinks of the deal. But b/c only 15 institutional investors hold about half of Laureate's shares, "it would probably not be that hard to gather opposition to the deal," says Hong.

Tuesday, April 17, 2007

Calls of Note Part 3

- Goldman Sachs continues to be negative on Labor Ready (NYSE:LRW) reiterating their Sell rating on share ahead of 1Q2007 earnings to be announced on Thursday, April 18 (AMC). In firm's opinion, 2007 guidance and consensus estimates are too high given incremental housing weakness witnessed since the beginning of 2007. This note addresses the three primary areas of pushback from investors when they downgraded shares of Labor Ready on April 4: 1) Is this call too late? No. 2) Firm's $13 target price implies a new 52-week low - why? The housing market is at 52 week lows. 3) How does GSCO's below consensus estimate differ from the street? - They expect no 2H2007 recovery.

Catalyst: Labor Reay reports earnings on April 18. GSCO thinks 2007 EPS guidance of $1.25-1.30 is too high. The company cannot avoid negative earnings pressure due to its direct and indirect exposure to US residential construction activity. Since the beginning of 2007 firm's expectations for the US housing market have eroded; however, we have not, in firm's opinion, seen sufficient downward revisions to LRW guidance or Street estimates.

Notablecalls: Love the call! Wish the chart would agree with it more.

Calls of Note Part 2

- CIBC notes they remain bullish on NutriSystem's (NASDAQ:NTRI) near-term outlook. Firm believes that 1Q07 results should be reported at least in line with their estimate of $0.90 per share, with new customer adds of about 300K. NTRI will report 1Q07 earnings on Wednesday, April 25th.

Firm's analysis of comScore data indicates that traffic to online diet sites continued to slow yoy in 1Q. But nutrisystem.com's traffic share of top diet sites was stable while yoy growth rates in total traffic, and particularly for male traffic, outperformed other top sites.

NTRI shares are trading at 15x FY08 EPS estimate or 17x next 12-months estimated EPS. The latter compares to historical average of 28.5x and a hi-lo range of 47.6x-13.7x. Given the momentum they see in NTRI's business, they'd be opportunistic buyers at this level.

Firm continues to see strength in NTRI's business. Its product and service offering as well as marketing are favorably positioned to target male dieters. Negatives include tough existing and new competition, slowing online traffic trends in the sector, and volatility in the stock.

Notablecalls: Expect to see some buy interest in NTRI following the call. Look for an opening range breakout before stepping in.

Calls of Note Part 1

- Piper Jaffray says that consistent with their cautious Motorola (NYSE:MOT) outlook and recent monthly handset channel checks , they are lowering their June quarter and 2007 estimates for Motorola ahead of its earnings report.

Based on belief Motorola will focus on reducing channel inventory during Q207 combined with limited new products ramping during the quarter, the firm islowering Q207 Motorola unit estimate from 54M to 50M units. Checks on the important mid-tier segment indicate the RAZR/KRZR continue to struggle in the market versus improving WCDMA products from Sony Ericsson, Samsung, and LG and Nokia's 6300 in the mid-tier China market. Further, Motorola appears focused on improving profitability and conceding share in the low-tier. PJ believes the transition from the C-series to the W-series should positively impact operating margins, they believe this transition will take months and have more of an impact during 2H07. Further, checks indicate MOTOFONE sales remain below expectations.

2007 proforma EPS estimate goes (excluding stock-based compensation) from $0.63 to $0.51 and 2008 estimate from $1.17 to $1.07. Maintains Market Perform and lowers tgt to $17 from $18.

Notablecalls: Nothing really surprising here. I continue to stand by my MOT rec. Carl Icahn provided a positive surprise last week, announcing an increase in his stake. He also sent a letter to MOT shareholders asking to elect him to the Board of Directors.

Color on warning: Fair Isaac (NYSE:FIC)

Several firms comment on Fair Isaac (NYSE:FIC) after the co last night issued a warning for FY07:

- Citigroup is downgrading the stock to Hold from Buy saying that while the news will help establish a conservative base of numbers for FIC to grow off of, they do not see any catalysts in the stock as the market will likely take a more cautious stance on FIC's restructuring and as the firm believes an LBO may be more difficult in the near term given the potential for investor backlash. Firm is trimming their target to $37 from $53 to reflect the lower expectations and lack of near-term catalysts.

- William Blair notes they believe the company has moved aggressively in setting the bar low for the upcoming year.

The company blamed the earnings miss on lower revenue than expected, coupled with negative leverage. Part of this is ongoing fallout from last year's reorganization of the salesforce into vertical industry teams, or ICNs, which is having more disruption than planned. Also contributing was execution failure at the 11th hour, as a number of deals slipped past the March 31 quarter-end, but have been subsequently signed. Finally, a delayed rollout of the newest version of the Falcon fraud product also hindered sales in the quarter. The company blamed softness on bookings in the mortgage, fraud, and insurance bill review verticals; however, it did not attribute softness in the subprime mortgage sector for any revenue weakness. It also reported that it has not seen any attrition in FICO scores from the Vantage Score.

The new CEO Mark Greene said on the follow-on conference call that the quarter's weakness was a surprise, but that the reasons for the weakness are not. In follow-up conversation, he describes himself as disappointed in the quarter but in no way discouraged in his vision, and ready to move past this quarter and begin moving forward.

The new CEO's evaluation, after meeting with customers and employees, is that the company still maintains a reputation for cutting-edge analytic products, but has developed a reputation to be arrogant and difficult to work with. This confirms what the firm has heard in industry contacts. Even so, Dr. Greene's estimation is that clients and prospects want to do more business with the company, but need the whole customer experience enhanced, from marketing to sales contact to simpler product bundles to after-sale support. One example of movement in this direction is that the company now has senior executives assisting in relationship building and selling at its top 25 clients.

William Blair thinks these moves are all positives and reflect needed changes, based on their conversations with people in and around the company. the challenge will be getting them to bear fruit, particularly as measured by improved organic growth, where the new CEO sees success as moving nearer to industrywide growth rates in the high-single-digit range, with EPS growth supplemented by operating leverage and share repurchases. But they think the worst is now behind the company and that the next year will bring slow improvement to financial results.

- JP Morgan notes that somewhat surprisingly, management indicated on the follow-up call
that 2Q's revenue shortfall was more execution driven than cyclical. The revenue impact was largely from the change in sales approach and the Falcon upgrade delay. Management, under the new direction of Mark Greene, could be setting the FY07 guidance bar low after numerous earnings misses in recent years.

Mark Greene named a new COO and Chief Technology Officer. JPM likes the reorganization of the sales force but the changes, including training and new support teams, could take
time to implement.

Reiterates Neutral, with FIC trading at 24.7x F2007E EPS. While they believe management could be setting the bar low, they expect the sales 'reorganization' to take time to effectively execute. In addition, there could be cyclical pressures on segments in the coming quarters. After substantially reducing 2007 guidance, FIC is trading at the high end of its historical 15-25X forward 12-month EPS.

- JMP Securities says that although the numbers are clearly disappointing, the firm was encouraged by the new CEO's direct approach in recognizing the customer issues that the company has developed over the past years and in his vision to address these issues. Further, they believe that his vision to refocus Fair Isaac around its core products and away from a professional services focus also plays to the company's historical strengths.

Although in JMP's view the company now has the right vision, they also believe the execution of this plan will take some time with management looking to 1Q08 (December 2007) before it will begin to see the benefits of this turnaround. For FY07, they are lowering EPS estimate from $2.11 to $1.62. For FY08, they are lowering EPS estimate from $2.40 to $1.79. Maintains Mkt Perform rating.

Notablecalls: Must say I've had FIC on my radar as a potential short for some time already with sales force reorganization being the first red flag. Often enough, these reorganizations act as the canary in the coal mine, signalling problems to come.

I think we can safely assume FIC can generate EPS of around $2 in FY08. The stock ended at around $36 in after hours action implying an EPS multiple of about 18x. Given the seemingly s-t nature of FIC's problems, that's not too much. I really liked the comments of CEO Mark Greene regarding getting the house in order. Citi's downgrade (and there may be others) will hopefully push the price toward the $35-$35.5 levels, providing a possible buying opportunity for aggressive accounts.

Paperstand (TWX, KO, NCT)

The WSJ reports that inside Time Warner (TWX), senior execs are considering what was once unthinkable: whether the co should substantially reduce its cable-TV holdings over time. Cable has been a core part of the co and its precursors for decades and is now the biggest contributor to profits. But the long-term future of cable, as the Internet emerges as a viable venue for watching TV, is murky. Some within Time Warner wonder whether the co wouldn't be better off if it were to get out of cable and double down on the Web, where it already owns AOL, by buying another major Internet co. Likely is that Time Warner will decide to gradually reduce its 84% stake in Time Warner Cable (TWCAV.PK), possibly through acquisitions, while still maintaining a significant interest.

“Heard on the Street” column discusses Coca-Cola (KO), saying that since its Jun’05 debut, Coke Zero has sold more than 100m unit cases. While that is a fraction of the sales of Diet Coke or Coca-Cola Classic, the new drink is the co's "most successful launch...of any brand in 20 years," according to Chmn and CEO E. Neville Isdell. Some outsiders see signs of a bigger turnaround that reflects improving product development by Coke scientists, snazzier marketing and patched-up relations with bottlers, all areas where Coke was hurt by massive layoffs a few years ago. If the current trend holds, Mr. Isdell could win over skeptics who complain that Coke's glory days are a thing of the past. "We think the co has gotten momentum," says David Kolpak, of Victory Capital Mgmt. Unfortunately for Coke, the success of Coke Zero hasn't produced a jolt for its stock price yet. Coke shares are up 22% in the past year. Analysts say much of the rise is a result of strong growth in emerging mkts where consumers aren't bored by sodas.

Barron’s Online “Inside Scoop” section reports that 3 Newcastle (NCT) execs have buttressed their holdings with a total of $24.1m in shares of the REIT. Chmn Wesley R. Edens and Secretary Randal A. Nardone each bought 432K shares for $12m. The two men made their purchases as part of a secondary offering of 4.6m. Edens now beneficially owns 2.5m shares, a 4.7% stake, while Nardone beneficially owns 2.3m shares, a 4.3% stake. CIO Phillip Evanski joined, spending $71K on 2.5K shares. Jonathan Moreland, of InsiderInsights.com, says that the purchases at Newcastle echo an uptick in insider sentiment at other financial firms after the subprime-mortgage crisis-induced selloff. "I have recommended that ppl nibble at some of the oversold shares in this sector, and Newcastle is just as good as any," says Moreland.

Monday, April 16, 2007

Calls of Note Part 4

- Thomas Weisel Partners commented on First Marblehead (NYSE:FMD) over the weekend in light of Sallie Mae (NYSE:SLM) acquisition.

Acquisition discussion highlights First Marblehead density disk: As FMD's largest customer (JPM, 25% of total service revenue) is reportedly involved in proposals for SLM, the potential for volume losses appears significantly increased. Firm notes that FMD's three primary volume contributors (JP Morgan, Bank of America and Charter One) account for 52% of total service revenue.

Loss of JP Morgan may result in 26% reduction of loan volume and 27% of earnings (based on 2006 earnings): While the company has increased the number of other lending partners, they note that (since JP Morgan purchased CFSI and pulled out from its SLM partnership) FMD's dependence on JP Morgan has increased.

TWP believes that the potential SLM transaction highlights the rising concern that both JP Morgan (note November 2005 CFSI acquisition and potential near term loan securitization) and Bank of America (renegotiation of contract in Summer 2007) may begin to originate and retain private loan volumes in order to provide additional services (bank accounts, credit cards) that the highly educated and leveraged customer base. Thinks FMD shares are fairly valued at current levels.

Notablecalls: What TWP did not know over the weekend and what we know now, is that both JPM and BAC are included in the group that is offering to buy SLM. Expect to see downside in FMD.

Calls of Note Part 3

- Baird is cautious on Pool Corporation (NASDAQ:POOL) lowering their tgt to $40 from $41 after reducing 1Q07 EPS estimate from $0.10 to $0.07 (consensus) with other minor fine-tuning. Temperature data, channel checks and comparable-company reports imply a lackluster 1Q07 and 2007 outlook for POOL. They remain cautious on the stock going into the quarterly release and key selling season.

Firm's channel checks imply that MRO sales (approximately 60% of POOL's gross profits) are about as expected, nationwide. Their concern has been the 40% of gross profits driven by new pool construction. Cyclically, annual change in median home value (ammunition for aftermarket pool construction) will likely fall for the first time in POOL's public history during 2007 -- perhaps more acutely in key sunbelt states.

Weather has not cooperated in 2007. Distributors across in middle and northern states responded that the selling season should have started three weeks ago, but hasn't. Other sellers of discretionary consumer productsare seeing weak conditions. Last week, Marine Max (HZO) announced a weaker 2007 outlook. Polaris (PII) confirmed last week that end demand for ATVs, motorcycles and snowmobiles remains weak. POOL is scheduled to report on April 19.

Baird rates POOL Neutral, Higher Risk based on 11.5x EV/ 2007E EBITDA, which is a slight discount to historical average of 12x. The target also represents 20x 2007E estimate of $2.03, which is approximately the average historical valuation since 1998.

Notablecalls: POOL has proved to be a smart shorting opporunity over the past year or so as it is closely tied to the housing industry. Given the high likelyhood of futher downside in housing, POOL's likely disappoint over the next year or so.

Calls of Note Part 2

- ThinkEquity is upping their tgt on Sigma Designs (NASDAQ:SIGM) to $40 from $30 based on
what we believe to be ongoing strong design wins and deployment activity. Firm only sees one major threat to this story, and that is competition. Fortunately, they believe the design wins already won by SIGM should be able to drive the stock materially higher for another 12 months.

Firm is increasing their FY08 and FY09 revenue estimates from $139M and $180M to $159M and $205M. For the same time periods, they are increasing their untaxed EPS estimates from $1.18 and $1.56 to $1.52 and $1.97.

As for the estimates, the firm caution that they do not know what the gross margins or any other expense/income items below the revenue line have been in the last few quarters. As such, they fear that their historical estimates may be adjusted downwards once they obtain the full information. Firm estimates the current fully diluted market cap to be close to $728M based on 28M shares. With cash being nominal, they call that a $700M enterprise value. They believe the stock should trade at close to $1.1B plus the cash, or $40 per share, a year from now.

The driver for the stock over the last five quarters has been IPTV in the form of set-top boxes from companies such as Motorola. Firm believes this will continue to be the main driver for the next 12 months, but that it will also be augmented by strong design wins in other areas, including digital media adapters (DMAs), DVD players (Blu-Ray), portable media players (PMPs) and TV sets.

Notablecalls: Expect to see buy interest in SIGM today.

Calls of Note Part 1

- Piper Jaffray notes they attended the NAB tradeshow yesterday. NAB is the largest show for broadcast & post production companies. The two key themes at the show this year were: 1) the move to HD -- which has been a theme for the last several years, and 2) growth in web based video -- which has been a topic in the past and is becoming a bigger theme. Firm believes the general health of the broadcast & post production industry remains strong, and they would focus on companies positioned to capture business from one of these two major industry trends.

Apple (NASDAQ:AAPL) introduced Final Cut Studio 2, which is an update to its existing video production suite (continues to be priced at $1,299). More importantly, Apple introduced Final Cut Server, an asset management and workflow automation tool. Apple has consistently been criticized for not having a way for pro editors to tackle high end projects, given the lack of tools allowing editors to work collaboratively and manage the workflow of big projects. PJ believes the release of Final Cut Server is a sign that Apple is trying to push Final Cut into higher end projects. A higher end version of Final Cut has been rumored for 2 years, but it failed to materialize again this year.

Apple's announcements at NAB yesterday are not big news compared to the company's other product announcements this year, and the firm does not expect that these announcements will impact numbers in the near term. Maintains Outperform and $123 tgt.

Notablecalls: A non event for AAPL but given the lack of higher end version of Fincal Cut, there may be some buy interest in AVID. Please see archives for further color on the topic.

Color on data: Vertex Pharma (NASDAQ:VRTX)

Several firms comment on Vertex (NASDAQ:VRTX) after the co presented additional efficacy and safety data from the ongoing ph.IIb PROVE 1 study of telaprevir in hepatitis C (HCV), including SVR20 data from a 12-week treatment arm of telaprevir plus standard of care (Peg-IFN/RBV).

- CIBC notes that among 17 "intent to treat" pts in the 12-wk telaprevir/Peg-IFN/RBV arm, 6
achieved SVR20 (35%). Firm believes these are solid but not spectacular results; they would caution against over-interpreting this data due to the potential for statistical variability from the very small sample size.

They believe the rate of rapid virologic response for pts on telaprevir was impressive (79% vs. 11% for placebo), suggesting an additional 12 wks of Peg- IFN/RBV may be sufficient to suppress rebound and improve SVR. Importantly, there were no unexpected safety issues vs. prior data.

CIBC would expect some downside in VRTX, given inflated expectations for the 12-wk treatment arm at EASL. However, they continue to believe the totality of the ph.IIb data will support telaprevir's strong clinical profile and $2B mkt potential. Firm would use any weakness as a buying opportunity. Maintains Sector Outperformer and $42 tgt.

- Morgan Stanley says the data continue to suggest VX-950 is a potent drug that, when added to current drugs, improves patient outcomes and - at least until a better tolerated, more potent, or more convenient drug comes along - has a place treating hepatitis C. However, these data do not live up to investors and managements' aggressive assumptions, and timelines and revenue numbers are likely slipping across the Street as a longer treatment duration (six months) shrinks growth in the addressable population and pushes time to market further away (a randomized, controlled trial for Phase III looks increasingly likely). Firm is delaying their expected launch of VX-950 until 2010, which is significant given the company's current burn, and lowering long-term revenue estimates.

Even after Friday's leak of the data and sell-off, they expect further weakness as investors digest longer timelines and a longer treatment duration. Bigger picture, the firm continues to view VX-950 as a meaningful advance in HCV care, and the protease inhibitor class will ultimately change the HCV treatment paradigm (but continues to fear VX-950 could be Crixivan).

- Prudential says complete analysis of the entire set of data and the confirmation that there is no major side effect related to telaprevir treatment led them to conclude that telaprevir is still on track to enter the market as the first HCV protease inhibitor. Firm believes, based on available data, that the 24 weeks (12 weeks of telaprevir plus standard of care followed by 12 weeks of standard of care) of treatment should result in efficacy better than standard of care. The improved efficacy and the shortened treatment duration still make this new combination a game changer, although slightly less robust than they previously thought.

Although the number of patients available for evaluation was small in Arm D, the SVR12 data was highly anticipated by the Street and they think the stock is likely to react to the consensus interpretation of the data. On the most bearish side, one can argue that the response was only 35%, significantly lower than the number of 75% some hoped for long before PROVE 1 was started. Firm thinks the Street's expectation going into EASL was lowered, probably to the 50% range. If that were true, then the number would still be below expectation and they think the stock would be under pressure in the near term.

However, they think the most informative calculation is that 46% of patients in Arm D achieved a SVR12 after only 12 weeks of treatment with telaprevir and the standard of care. If the patient that withdrew with consent was taken out of the calculation, the SVR12 rate would be 6/12, or 50%, in line with the Street's expectation before EASL. If the consensus view would take this number, then the stock should not move too much as EASL. They are particularly relieved that no serious side effects were seen in the complete safety analysis.

Prudential believes the stock has passed its most speculative phase and recommends investors to accumulate shares. Maintain Overweight and $45 tgt.

Notablecalls: Expect to see downside in VRTX today. If MSCO's right, timelines will be pushed back in a major way, plus there will be no new data coming until Nov. On the other hand, there is very little doubt regarding the efficiency. Once launched, telaprevir will surely be part of the standard treatment for HCV, with $1-$2 billion market potential. Aggessive trading accounts may see buying opportunity around the -10% level today.

Paperstand (SLM, GOOG, MRK, HNR)

The WSJ reports that Sallie Mae (SLM) agreed to be sold to two private-investment funds and banks JP Morgan and Bank of America for $25bn, putting the embattled co into private hands at a time of intense political scrutiny of the student-lending industry. JC Flowers and Friedman Fleischer & Lowe plan to take a 50.2% ownership in the newly private firm, with JP Morgan and BofA each taking 24.9% stakes in the co. The buyout group plans to pay $60 per share, nearly a 50% premium to where its shares traded on Thu, before word leaked out of a possible transaction.

According to the WSJ, Google (GOOG) plans to begin selling advertising on more than 675 radio stations owned by Clear Channel Comm. (CCU), in a move designed to add scale to the co's offline ad-brokering efforts and boost Clear Channel's rev.

The WSJ discusses Merck’s (MRK) new vaccine against cervical cancer, Gardasil. The co lobbied dozens of states to make the vaccine mandatory for 11 and 12 year-old girls. The campaign scored some big victories. The CDC declared all women age 11-26 should get the vaccine. But behind the scenes, Gardasil has been dogged by uncertainty about how effective it really is. The FDA didn't ask its panel of experts advising on Gardasil to rule on whether the vaccine specifically prevented the cancer itself. In clinical trials, 361 of 8,817 women who received at least one shot of Gardasil went on to develop precancerous lesions on their cervixes within 3 years of vaccination, just 14% fewer than in a placebo control group. Scott Emerson, a professor of biostatistics at the University of Washington who sat on the FDA advisory committee, says he's not persuaded the vaccine is worth the billions of dollars likely to be spent on it in coming years. "I do believe that Gardasil protects against HPV 16 and 18, but the effect it will have on cervical-cancer rates in this country is another question entirely," says Dr. Emerson. Safety is another issue. Merck tested the vaccine in only a few hundred 11 and 12 year-old girls. Some doctors consider that number too small to declare the vaccine safe. In its approval letter, the FDA ordered Merck to follow "a sufficient number of children 11-12 years of age" in a large postmarketing study to further establish the vaccine's safety. That study won't be completed until ‘09.

Barron’s Online “Inside Scoop” section reprots that value investor Mohnish Pabrai's gushing purchases of Harvest Natural Resources (HNR) indicate that the stalemate caused by Venezuela's move to partially nationalize E&P co’s may be near completion. Pabrai, of Pabrai Investment Funds, has spent more than $12.3m to purchase 1.3m shares of Harvest. Ben Silverman, of InsiderScore.com, says that Harvest's prospects are riding on the co gaining final approval from the Venezuelan govt. But considering that Harvest is Pabrai's sole energy play in a concentrated portfolio, Silverman says the value investor "sees the forest through the trees [and] his continued investment here suggests that he has a lot of faith in the name."

Sunday, April 15, 2007

Barron's Summary

Barron’s cover highlights Adobe (ADBE), whose shares have climbed from a ‘01 low of 8.35 to recent 42. But there looks to be plenty of upside left, thanks in no small part to a promising series of product launches slated for the next 3 mo’s. They represent Adobe's first effort to fully integrate its own products with those it gained through the acquisition of Macromedia. The stock doesn't look cheap, at least at first glance. It's changing hands at 28.6x F'07 earnings of $1.48 a share. But looked at in terms of its whopping free cash flow, Adobe is far more attractive: FCF amounts to more than 30% of sales, making the co one of the mkt's most notable cash kings. What's more, the consensus earnings ests of roughly 20% growth may seriously underestimate the real 12-mo potential; it could be as high as 30%. "Adobe stands to benefit from a whole bunch of mega-trends, including the sheer growth of the Web and broadband penetration," argues Jeffrey Hammond of Forrester Research. Bulls figure the shares are headed to at least 50 within a year.

The shares of K-Swiss (KSWS), at a recent 27, are off more than 25% from their 52w high. But the co's turnaround plan could easily lift the price to 32. Some of Street's best bargain hunters already are lining up behind K-Swiss. In mid-Feb, Martin Whitman's storied Third Avenue Mgmt reported holding 2.3m shares, or 8.8% stake.

Office Depot (ODP) trades for 35, or 15x estd earnings, a discount to Staples' (SPLS) 18. The stock could rally into the mid-40s as earnings continue to climb. Office Depot represents "pretty good value," says Bill Collier, of SunTrust. He's been buying more shares recently, and has a 12-mo tgt in the mid-40s. Besides, "the private-equity factor keeps a floor" on many retail stocks, he notes, though he does not necessarily expect Office Depot to become a buyout candidate.

“The Trader” column out saying that last Thu, investors sent shares of the Brunswick (BC) down 4%. The catalyst: yet another warning from the boat retailer MarineMax (HZO), Brunswick's largest customer. Brunswick won't report earnings until April 26, but MarineMax's dire forecast could be a bad omen for those hoping that the worst is over for the slumping boat mkt. But as customers like MarineMax start cutting orders, Brunswick may not be able to reduce production in time to avoid excess inventory, notes Hayley Wolff, of Rochdale Securites. Price discounting and margin pressures further threaten to sink the spring and summer selling season. At 30.6, Brunswick shares trade at 17x estd ‘07 EPS of $1.80. Analysts think profits will bottom this year and rebound to $2.15 in ‘08, but such ests, and the timeline, may prove too optimistic.

“International Trader” column has serious doubts on Ryanair’s (RYAAY) plan to start budget trans-Atlantic routes. A trans-Atlantic operation would immediately face much higher cost pressures, particularly for personnel. Safety rules dictate that air crews rest about 12 hours after a long flight, so the long-haul carrier would have to pay for its crews' hotels and transportation. What's more, the larger airplanes required couldn't be turned around within 90 minutes and would need far more fuel than the short-haul Boeing 737s it now uses. To help offset these higher costs while still offering low economy-class fares, Ryanair USA would need a premium-class section on its planes. Premium-class sections are key profit generators for long-haul airlines and are typically filled by execs jetting between major financial centers. Few are likely to want to go to the secondary airports.

“Follow Up” section discusses another round of takeover speculations on Dow Chemical (DOW). Investors will be further heartened to know that the co's parts might be worth more than its whole. According to Deutsche Bank analyst David Begleiter, a sum-of-the-parts valuation pegs the co's worth at $55, nearly 20% above the stock's recent price. To enhance shareholder value, Bear Stearns analyst Victor Miller has written, Clear Channel (CCU) could spin off its domestic billboard unit and sell its intl billboard operations. Clear Channel already is selling hundreds of its small-mkt radio stations and its TV business, which could raise $2.5bn. Miller has argued that Clear Channel is worth about $44 a share, without leveraging itself to repurchase stock. Despite a 2% boost in sales provided by Panera's (PNRA) new Crispani flatbread pizza, the additional labor and promotional expenses connected with it are pressuring operating margins. This is making some investors doubt that the co can meet its tgt of 25%+ earnings growth over the next 3 years. Panera says it is sticking with the tgt. But in the bitterly competitive, price-sensitive and increasingly saturated casual-food business, it might be biting off more than it can chew.

“Technology Trader” discusses Cepheid (CPHD), whose shares shot recently up in sympathy to Biosite takeover. But, according to the article, one simple difference is that Biosite earns robust profits, as Cepheid repeatedly has claimed to have found a profitable application for its tests. But Cepheid's achievements have fallen short of its forecasts. The co predicted it would make a profit in ‘06, for example. Instead, Cepheid's losses nearly doubled. Now CEO John Bishop eagerly directs investors' attention to the next big opportunity for Cepheid: infection-control testing at hospitals like those run by the Dept of Veterans Affairs. Cepheid glowingly predicts a $1.25bn annual mkt and Bishop believes that infectious-disease testing will bring Cepheid operating profits by the 4Q07. One of the few analysts to attempt a reasoned est of the veterans opportunity for Cepheid is Daniel Owczarski of Soleil. Owczarski concludes that the VHA program would add just over $1m in test sales to the co's annual rev. That wouldn't do a lot to reduce Cepheid's annual losses.

Notablecalls: Expect to see some profit taking following the Barron's call and a sharp increase in stock price.

“Plugged In” column out saying that Apple (AAPL) delay is no big deal. Late Thu, the co announced that the iPhone had "passed several of its required certification tests" and is on schedule to ship on time. The co added that finishing the iPhone on time "has not come without a price. We had to borrow some key software engineering and quality-assurance resources from our Mac OS," which means that the Leopard won't be ready to ship in time for Apple's developers' conference in June. " Leopard's delay isn't very important, says Charles Wolf, of Wolf Insights. "The long-term impact will be absolutely zero," Wolf says. "But it might postpone the upgrade cycle by a quarter or so."

Columbia Mid Cap Value Fund top 10 holdings include: PCG, ETR, APD, EIX, PPL, GGP, CMA, HES, ZION and CIT. Group's current favorites include MTD, HSC, NOV, EL and ATVI.

Friday, April 13, 2007

Color on Quarter: Lam Research (NASDAQ:LRCX)

Lam Research (NASDAQ:LRCX) getting plenty of comments following quarterly report.

- Citigroup says that Lam not only blew through consensus (EPS of $1.15 vs. $1.06), but it also raised its C07 EPS guidance significantly to $4.50-4.70, from $4.10-4.30. They were at $4.52 going into the call while consensus was at $4.05. Firm expects consensus to again rise to meet their estimates. C2H07 shipment guidance was also increased due to a smoothing of memory shipments, higher confidence by management in the sustainability of memory spending, and a pickup in Foundry activity.

While Lam is forecasting C2H07 shipments to be down 7% from C1H07, this is substantially better than the down 18% it was forecasting previously. Firm anticipates additional Foundry activity and unexpected turns business for Flash (which occurred in the prior 2 yrs) will drive upside shipments in C2H07. As they have forecasted all along and contrary to consensus, C07 is shaping up to be a strong year and the implosion in memory that the market was fearing appears unlikely to materialize.

- Morgan Stanley says LRCX had solid March Q with revs/EPS/shipments all better than their/consensus expectations. Half of the EPS upside ~$0.05 driven by better operating performance and the other half by a better tax/stock buyback strategy. June Q revs/EPS guidance of $665MM/$1.15 much better than their/consensus expectations but shipments guided slightly lower by ~$15MM (excludes March upside) versus their model. Management attributed lower shipments to a smoothing in memory related projects (we believe Nanya and Samsung-Austin). Checks suggest the smoothing to be normal 1-2 month fab timing related issue for the industry.

- ThinkEquity believes investors could be underestimating the magnitude of decline in memory spending. While the logic and foundry segment should recover from very depressed levels, the production capacity expansion is likely to be at 130nm and 90nm, the nodes where Lam's share is not as high. While virtually all DRAM and flash devices are at 65nm, the median logic and foundry segment is still at 180nm, moving toward 130nm. As the foundry and
advanced logic segment recovers, firm anticipates capacity (as opposed to R&D and tapeouts) spending primarily at 90nm and 130nm nodes, where Lam's share is much lower.

- Bank of America notes that memory customers are slipping shipment dates at LRCX. Prior forecast for June shipments was greater than 25% Q-o-Q growth; it is now 10-15%. Firm suspects Samsung contributed the most to that change in outlook. Memory remains at very high levels as a percent of the mix, 78% in the March quarter.

The shipment push outs in conjunction with a sharp decline in first quarter memory prices and the surge in memory investment over the last 5 years suggest to us that they are in a topping out process for the memory cap-ex cycle. Firm would use the recent run in the stock above $50 to lower exposure.

Notablecalls: Current year's memory capex is still very much first half loaded and shipment pushouts only magnify this theme, lessening the willingness for second half orders. Samsung, largest memory capex spender by far also echoed this, noting that close to 40% of memory capex was already spent in the first quarter. Also, Samsung is pushing 200mm to c2009 and pushing out NAND shipments, probably in conjunction with the oversupply. DRAM is still having oversupply. LRCX mgmt's comments and guidance seem to be somewhat in disconnection with the big picture. Alltogether, I would expect the stock to trade down today. Not a very high conviction call, though.

Calls of Note Part 3

JMP Securities says that Clayton Holdings' (NASDAQ:CLAY) recent comments suggested that their 1Q revenue estimate is low and that their EPS estimate is achievable despite a perfect storm of cataclysmic events in the quarter for the subprime MBS market. By providing outsourcing services that span the entire lifecycle of a non-conforming mortgage from origination to post-securitization surveillance, Clayton has a unique and dominant franchise within a growing marketplace. Firm continue to believe that the company is poised to emerge from 2007 in a stronger position than it started in terms of Wall Street dealers' market share of securitizations, demand for greater due diligence rates on purchased portfolios, possible special servicing mandates, successful new product roll-outs, and new clients entering the customer mix.

Firm notes that management commented that revenue for the quarter should be a "couple of percentage points" below the first quarter of 2006, which would imply about $53-54 million, versus firm's $48 million estimate. On the gross margin front, they communicated expectations of mid-30%s, not far from firm's 38% forecast. They have two general observations. First, the ability to generate over $50 million of revenue during a quarter when the subprime
securitization market practically shut down attests to the breadth of services and some of the "counter-cyclical" or mitigating trends they see, such as rising due diligence rates. Second, the ability to deliver mid-30% gross margins seems to be a validation of the variable cost labor model that it employs. Specifically, the overwhelming bulk of its employees consist of contractors that are hired on an "as needed" basis to handle deal flow, not full-time employees that burden Clayton with fixed costs.

Notablecalls: See that big fall between March 8th and 13th? That's when the worries about the quarter were spreading. Now it looks as the quarter is just fine. Expect to see a strong interest in the shares today.

Calls of Note Part 2

JP Morgan is removing Itron (NASDAQ:ITRI) from the JP Morgan Focus List as the stock price has exceeded their December 31st 2007 price target of $69.

Firm says some near-term caution is justified. They believe ITRI remains undervalued and there is potential for upward revisions to their EPS estimates for FY08 and beyond. However they don't expect significant growth of backlog in the next six months. In firm's view, large-scale AMI contracts will not be awarded until utilities have been able to assess the benefits of early AMI deployments in California and Ontario. They expect large awards to be made in late 2007/early 2008.

Firm also believe there's near-term risk associated with the pending Actaris acquisition. At minimum, ITRI will be hit with significant non-cash GAAP charges, but there might also be some near-term integration challenges. They expect the accretive benefit of the transaction to become evident in 2H07 - which might also justify revisions to EPS.

Notablecalls: ITRI is a mover and today the move is to south. After such a run hearing to be cautious will push at least some weaker hands to lock profits.